Sweden · Delayed Price · Currency is SEK Alligo AB Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw revenue rise 5.6% and adjusted EBITDA jump 53%, with strong organic growth across all regions, especially Finland. Cash flow and leverage improved, and the company advanced its acquisition and logistics strategies while maintaining a stable margin.
Fiscal Year 2025
-
Revenue grew 2.7% in Q4 with organic growth returning, driven by Sweden and Finland, while Norway lagged. Gross margin and cash flow improved, leverage decreased, and the dividend was raised. Market remains challenging but stable, with focus on sales, inventory, and acquisitions.
-
Q3 2025 saw improved profitability and margin expansion, driven by acquisitions, cost savings, and a stronger gross margin, despite continued weak organic growth and cautious market conditions. Net debt rose due to acquisitions but is expected to decline, with a strong M&A pipeline and positive long-term outlook.
-
Revenue grew 1.6% in Q2 2025, driven by acquisitions, while organic growth was negative. Cost-saving programs and efficiency initiatives are expected to support profitability in H2, with market stabilization most evident in Sweden. Leverage is elevated due to acquisitions but remains manageable.
-
Revenue grew 2.9% in Q1 2025, driven by acquisitions, while organic growth remained negative amid weak Swedish demand. Cost reduction programs and new initiatives like ReCare and Battery Lager integration are expected to support future profitability as market signals improve.
Fiscal Year 2024
-
2024 was marked by weak markets, lower organic growth, and margin pressure, but acquisitions drove total revenue up 2%. Stabilization is emerging, especially among SMEs, and management expects recovery in the second half of 2025.
-
Revenue grew 1% in Q3 2024, driven by acquisitions, but EBITDA and margins declined due to weak demand and unfavorable customer mix. Eight acquisitions, especially in welding, boosted sales, while cost controls and new service offerings support resilience. Market remains challenging but shows early signs of stabilization.
-
Revenue rose 1.8% year-over-year, driven by acquisitions, but organic growth declined 3.2% amid weak demand from SMEs. Seven acquisitions, cost reductions, and new product launches position the company for recovery, though margin pressure and market softness persist.